Pebble Labs, Virbac Working to Provide Solutions for Aquaculture Disease Prevention
Biotechnology company Pebble Labs and Virbac, a veterinarian pharmaceutical group have agreed to co-develop and commercialize solutions for disease prevention in aquaculture.
Pebble Labs noted that farmed fish demand is expected to double globally by 2040, which means the industry will need to grow by 60% to meet the increased demand. It also said that a significant amount of fish are lost each year due to disease, worth $50 billion, according to the announcement.
White Spot Syndrome Virus losses in the farmed shrimp industry are estimated...
To Read Full Story Login Below.